Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Braconi

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
Current Cancer Drug Targets|August 10, 2012
Non-coding RNAs as therapeutic targets in hepatocellular cancerChiara Braconi, Tushar Patel
Infectious Disease Clinics of North America|October 13, 2010
Cholangiocarcinoma: new insights into disease pathogenesis and biologyChiara Braconi, Tushar Patel
Seminars in Liver Disease|December 12, 2018
Noncoding RNA in CholangiocarcinomaMassimiliano Salati, Chiara Braconi
Frontiers in Medicine|July 2, 2015
Non-Coding RNAs in Primary Liver CancerMichele Ghidini, Chiara Braconi
Hepatology (Baltimore, Md.)|September 11, 2023
The rapidly evolving landscape of HCC: Selecting the optimal systemic therapyValentina Zanuso, Lorenza Rimassa, Chiara Braconi
International Journal of Molecular Sciences|April 3, 2021
Patient-Derived Organoids as a Model for Cancer Drug DiscoveryColin Rae, Francesco Amato, Chiara Braconi
Cancers|December 30, 2020
Pathogenetic Role and Clinical Implications of Regulatory RNAs in Biliary Tract CancerNduka Ofoeyeno, Emmanuel Ekpenyong, Chiara Braconi
Hepatology (Baltimore, Md.)|February 11, 2010
MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytesChiara Braconi, Nianyuan Huang, Tushar Patel
World Journal of Gastrointestinal Oncology|August 16, 2017
Emerging molecular targets and therapy for cholangiocarcinomaHamzeh Kayhanian, Elizabeth C Smyth, Chiara Braconi
Hepatology (Baltimore, Md.)|March 12, 2020
Biology and Clinical Application of Regulatory RNAs in Hepatocellular CarcinomaAntonio Pea, Nigel B Jamieson, Chiara Braconi
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Current Cancer Drug Targets|August 10, 2012
Non-coding RNAs as therapeutic targets in hepatocellular cancerChiara Braconi, Tushar Patel
Infectious Disease Clinics of North America|October 13, 2010
Cholangiocarcinoma: new insights into disease pathogenesis and biologyChiara Braconi, Tushar Patel
Seminars in Liver Disease|December 12, 2018
Noncoding RNA in CholangiocarcinomaMassimiliano Salati, Chiara Braconi
Frontiers in Medicine|July 2, 2015
Non-Coding RNAs in Primary Liver CancerMichele Ghidini, Chiara Braconi
Hepatology (Baltimore, Md.)|September 11, 2023
The rapidly evolving landscape of HCC: Selecting the optimal systemic therapyValentina Zanuso, Lorenza Rimassa, Chiara Braconi
International Journal of Molecular Sciences|April 3, 2021
Patient-Derived Organoids as a Model for Cancer Drug DiscoveryColin Rae, Francesco Amato, Chiara Braconi
Cancers|December 30, 2020
Pathogenetic Role and Clinical Implications of Regulatory RNAs in Biliary Tract CancerNduka Ofoeyeno, Emmanuel Ekpenyong, Chiara Braconi
Hepatology (Baltimore, Md.)|February 11, 2010
MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytesChiara Braconi, Nianyuan Huang, Tushar Patel
World Journal of Gastrointestinal Oncology|August 16, 2017
Emerging molecular targets and therapy for cholangiocarcinomaHamzeh Kayhanian, Elizabeth C Smyth, Chiara Braconi
Hepatology (Baltimore, Md.)|March 12, 2020
Biology and Clinical Application of Regulatory RNAs in Hepatocellular CarcinomaAntonio Pea, Nigel B Jamieson, Chiara Braconi
Pageof 10